Biologics

B cell targeted therapies

What are B cell targeted therapies? RTX (Rituxan): chimeric mouse–human IgG1κ monoclonal antibody directed against extracellular domain of CD20 antigen on B cells. B cells are eliminated by complement-mediated lysis, antibody-dependent cell-mediated cytotoxicity, or apoptosis. All peripheral B cells are eliminated within days. Patients who fail to deplete their B cells respond less well. Notably, Ig …

B cell targeted therapies Read More »

What bDMARDs are available to inhibit IL 17

What bDMARDs are available to inhibit IL 17 in the rheumatic diseases? Secukinumab (Cosentyx) is a human IgG1κ monoclonal antibody which blocks IL-17A. It is FDA-approved to treat psoriasis, PsA, and AS. Not effective for RA. • Available formulations: 150 mg/mL solution in a single-use Sensoready pen or prefilled syringe that is self-administered. There is also a …

What bDMARDs are available to inhibit IL 17 Read More »

ustekinumab

What is ustekinumab and why is it effective in PsA? Ustekinumab (Stelara) is a human IgG1κ monoclonal antibody that binds to the p40 subunit of both IL-12 and IL-23 preventing their binding to their shared cell surface receptor chain, IL-12β. The inhibition of IL-12 signaling abrogates Th1 response with reduction in TNF-α, IFN-γ, and IL-2 production. …

ustekinumab Read More »

What biologics can inhibit IL 5

What biologics can inhibit IL 5? What are its uses and toxicities? Mepolizumab (Nucala) is a humanized IgG1κ monoclonal antibody that binds to IL-5. This antibody inhibits IL-5 which profoundly affects the activation and survival of eosinophils. Half-life with subcutaneous administration is 16 to 22 days. • Available formulations: 100 mg of lyophilized powder in single-dose vial …

What biologics can inhibit IL 5 Read More »

What biologics are currently available to inhibit TNF α

What biologics are currently available to inhibit TNF α? ETN (Enbrel): a bioengineered molecule derived from Chinese hamster ovary cells, which consist of a fusion protein created by linking the extracellular binding regions from two TNF-RII (p75) receptors to the Fc portion of human immunoglobulin G1 (IgG1). This molecule is a dimeric soluble TNF receptor that …

What biologics are currently available to inhibit TNF α Read More »

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856